Skip to content

A Multi-Center Comparative Study for DG Gel Neutral

A Multi-Center Comparative Study for DG Gel Neutral

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055995
Enrollment
Unknown
Registered
2022-01-30
Start date
2022-02-07
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Gold Standard:Blood Test
Index test:Product name: DG Gel ABO-CDE Purpose of use / Intended use Reference Reagent for reverse blood typing test (Fully Automated Method, Manual Method) Product specifications: 4 x 12 cards/box
2 x 25 cards/box Registration certificate holder: Diagnostic Grifols, S.A. Agent: Grifols Pharmaceutical Technology (Shanghai) Co., Ltd. Storage conditio

Sponsors

The Seventh Medical Center of the General Hospital of the Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0.3 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Remaining anticoagulated venous whole blood samples and serum samples collected during routine clinical testing in various clinical trial centers; 2. For anticoagulant venous whole blood samples, the anticoagulant used can be EDTA, citrate or heparin sodium; 3. The visual sample volume shall not be less than 1 mL; 4. Sample validity period: Samples stored at 2 - 8°C, within 48 hours after collection;

Exclusion criteria

Exclusion criteria: 1. For ABO reverse typing test, clinical routine blood donor samples; 2. For Cross-match test, discordant samples for ABO blood group; 3. Visually inspect the samples with severe hemolysis, cloudy and contamination; 4. Samples with insufficient actual volume for test; 5. Samples that do not meet the sample collection and processing requirements; 6. Samples with incomplete information, which shall at least include sex, age, sampling date, sample type, clinical diagnosis information, and unique patient/sample identification (eg, medical record number / case number / outpatient visit number, patient ID, sample number); 7. Samples from babies younger than 4 months old.

Design outcomes

Primary

MeasureTime frame
Blood Test;

Countries

China

Contacts

Public ContactWu Tao

The Seventh Medical Center of the General Hospital of the Chinese People's Liberation Army

wut7175@sina.com+86 13522633112

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026